Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 2020

View Archived Issues

scRNA-seq of Trypanosoma brucei from tsetse reveals candidates for a transmission-blocking vaccine

Anti-IL-1b platelet conjugate prevents sterile inflammation and adverse cardiac remodeling after AMI

Positive data for RECCE-327 in models of kidney and UTI infection

Sihuan Pharmaceutical initiates phase III study of anaprazole sodium in duodenal ulcer

GeneTx receives approval to initiate phase I/II study GTX-102

Phase I data presented for fosciclopirox in advanced solid tumors

Bayer presents data from phase II/III FORT-1 study of rogaratinib

Preliminary data presented from POLARIS-03 study of toripalimab in UC

Hinova Pharmaceuticals discovers new BRD4 inhibitors

High affinity nerve growth factor receptor inhibitors presented by JC Pharma

New IDO-1 inhibitors identified at Bristol-Myers Squibb

Domain Therapeutics patents mGluR4 positive allosteric modulators

Dual mu-opioid/voltage-gated calcium channels alpha2/delta-1 subunit ligands synthesized at Esteve

Ebola survivor's antibodies reveal therapeutic targets

Origin story helps ovarian cancer prognosis

Kinase, caspase play unexpected roles in NASH

MAO-A inhibitor phenelzine shows promise for treating recurrent prostate cancer

Phase I preliminary data presented for ACTUS-101 in late-onset Pompe disease

The Year's New Drugs & Biologics reviews 2019's new drugs and candidates for 2020 approval

FDA approves Twirla contraceptive patch

Beovu approved in E.U. for wet AMD